{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:06:21Z","timestamp":1780596381035,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases","award":["U01 DK61700"],"award-info":[{"award-number":["U01 DK61700"]}]},{"name":"National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases","award":["T32DK007777"],"award-info":[{"award-number":["T32DK007777"]}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1053\/j.ajkd.2016.01.019","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T05:06:15Z","timestamp":1456895175000},"page":"277-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial"],"prefix":"10.1053","volume":"68","clinical-trial-number":[{"clinical-trial-number":"nct00064753","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Taimur","family":"Dad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hocine","family":"Tighiouart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alin","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bostom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Hunsicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Kusek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2016.01.019_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacc.2012.05.008","article-title":"Cardiac disease evaluation and management among kidney and liver transplantation candidates","volume":"60","author":"Lentine","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1053\/j.ajkd.2016.01.019_bib2","unstructured":"NKF. Organ donation and transplantation statistics (as of September 8, 2014). http:\/\/www.kidney.org\/news\/newsroom\/factsheets\/Organ-Donation-and-Transplantation-Stats.cfm. Accessed October 27, 2014."},{"key":"10.1053\/j.ajkd.2016.01.019_bib3","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/j.1600-6143.2012.04101.x","article-title":"Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial","volume":"12","author":"Weiner","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2016.01.019_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-6143.2009.02949.x","article-title":"Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplant (PORT) study","volume":"10","author":"Israni","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2016.01.019_bib5","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIR.0b013e3181e3b133","article-title":"Aspirin for primary prevention of cardiovascular events in people with diabetes","volume":"1121","author":"Pignone","year":"2010","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2016.01.019_bib6","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jacc.2007.02.020","article-title":"Evidence based guidelines for cardiovascular disease prevention in women: 2007 update","volume":"49","author":"Mosca","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1053\/j.ajkd.2016.01.019_bib7","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.jacc.2006.04.026","article-title":"AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update","volume":"47","author":"Smith","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1053\/j.ajkd.2016.01.019_bib8","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1097\/01.TP.0000129407.31494.45","article-title":"Low dose aspirin therapy is associated with improved allograft function and prolonged allograft survival after kidney transplantation","volume":"77","author":"Grotz","year":"2004","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2016.01.019_bib9","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.110.000588","article-title":"Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients","volume":"123","author":"Bostom","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2016.01.019_bib10","doi-asserted-by":"crossref","first-page":"448.e1","DOI":"10.1016\/j.ahj.2006.03.004","article-title":"Rationale and\u00a0design of the Folic Acid for Vascular Outcome Reduction in\u00a0Transplantation (FAVORIT) trial","volume":"152","author":"Bostom","year":"2006","journal-title":"Am Heart J"},{"key":"10.1053\/j.ajkd.2016.01.019_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.ajkd.2008.08.010","article-title":"Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) trial","volume":"53","author":"Bostom","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2016.01.019_bib12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2016.01.019_bib13","unstructured":"Harrell FE Jr, Dupont C. Hmisc: Harrell Miscellaneous. R package, version 3.16-0 (2015). http:\/\/CRAN.R-project.org\/package=Hmisc. Accessed November 17, 2015."},{"key":"10.1053\/j.ajkd.2016.01.019_bib14","unstructured":"Harrell FE Jr. Regression modeling strategies. R package, version 4.2-0 (2014). http:\/\/CRAN.R-project.org\/package=rms. Accessed April 15, 2015."},{"key":"10.1053\/j.ajkd.2016.01.019_bib15","first-page":"1","article-title":"MatchIt: nonparametric preprocessing for parametric causal inference","volume":"42","author":"Ho","year":"2011","journal-title":"J\u00a0Stat Software"},{"key":"10.1053\/j.ajkd.2016.01.019_bib16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.ajkd.2007.07.007","article-title":"Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"50","author":"Ethier","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2016.01.019_bib17","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2215\/CJN.02291205","article-title":"Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin","volume":"1","author":"Goldstein","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2016.01.019_bib18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/j.ajkd.2004.11.015","article-title":"First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease","volume":"45","author":"Baigent","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2016.01.019_bib19","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jacc.2010.02.068","article-title":"Aspirin is beneficial in hypertensive patients with chronic kidney disease","volume":"56","author":"Jardine","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2016.01.019_bib20","first-page":"S1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2016.01.019_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"10.1053\/j.ajkd.2016.01.019_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/j.ajkd.2012.08.030","article-title":"Emerging analytical techniques for comparative effectiveness research","volume":"61","author":"Brunelli","year":"2013","journal-title":"Am J Kidney Dis"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638616001438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638616001438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:46:30Z","timestamp":1759459590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638616001438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0272638616001438"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2016.01.019","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2016.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}